UBS Group AG - INFINITY PHARMACEUTICALS INC ownership

INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 80 filers reported holding INFINITY PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS Group AG ownership history of INFINITY PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$126
-98.5%
600
-98.9%
0.00%
Q1 2023$8,518
-31.4%
53,236
+140.2%
0.00%
Q4 2022$12,411
+520.6%
22,162
+1491.0%
0.00%
Q3 2022$2,000
-66.7%
1,393
-85.4%
0.00%
Q2 2022$6,000
-57.1%
9,509
+50.6%
0.00%
Q4 2021$14,000
-76.3%
6,312
-63.2%
0.00%
Q3 2021$59,000
+883.3%
17,145
+782.9%
0.00%
Q1 2021$6,000
+200.0%
1,942
+70.8%
0.00%
Q4 2020$2,000
-88.9%
1,137
-92.6%
0.00%
Q3 2020$18,000
+800.0%
15,461
+700.7%
0.00%
Q2 2020$2,000
-33.3%
1,931
-46.8%
0.00%
Q1 2020$3,0000.0%3,629
+137.8%
0.00%
Q1 2019$3,000
-66.7%
1,526
-79.8%
0.00%
Q4 2018$9,000
-52.6%
7,538
+7.4%
0.00%
Q3 2018$19,000
+533.3%
7,016
+321.9%
0.00%
Q2 2018$3,0001,663
+1563.0%
0.00%
Q4 2017$0100
-66.7%
0.00%
Q3 2017$03000.0%0.00%
Q2 2017$0
-100.0%
300
-40.0%
0.00%
Q1 2017$2,000
-90.9%
500
-96.9%
0.00%
Q4 2016$22,000
+2100.0%
16,091
+1911.4%
0.00%
Q3 2016$1,000
-88.9%
800
-88.7%
0.00%
Q2 2016$9,000
-25.0%
7,069
+207.3%
0.00%
Q1 2016$12,000
-98.8%
2,300
-98.3%
0.00%
-100.0%
Q4 2015$1,037,000
+3603.6%
132,064
+3755.9%
0.00%
Q3 2015$28,000
-6.7%
3,425
+24.5%
0.00%
Q2 2015$30,000
-14.3%
2,751
+10.0%
0.00%
Q1 2015$35,000
+40.0%
2,500
+66.7%
0.00%
Q4 2014$25,0001,5000.00%
Other shareholders
INFINITY PHARMACEUTICALS INC shareholders Q2 2022
NameSharesValueWeighting ↓
BVF INC/IL 6,353,645$4,017,0000.19%
Gratus Capital, LLC 1,117,154$706,0000.08%
Bleichroeder LP 250,000$158,0000.03%
Polar Capital Holdings Plc 5,000,000$3,162,0000.02%
PLATINUM INVESTMENT MANAGEMENT LTD 545,508$345,0000.01%
Ergoteles LLC 419,652$265,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 249,000$157,0000.00%
Y-Intercept (Hong Kong) Ltd 41,396$26,0000.00%
Heritage Financial Services, LLC 4,749$3,0000.00%
Evercore Wealth Management, LLC 143,138$91,0000.00%
View complete list of INFINITY PHARMACEUTICALS INC shareholders